# SCRT(Short Course Radiotherapy) Combined With CAPOX Plus QL1706 for Rectal Cancer Liver Metastases

Source: https://onco.cc/trials/nct06787183/  
OnCo record `nct06787183` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 2 trial of capecitabine, fOLFOX (5-FU, leucovorin, oxaliplatin) and QL1706 in colorectal cancer, run by Fujian Cancer Hospital, now recruiting.

## Summary

SCRT(Short Course Radiotherapy) Combined With CAPOX Plus QL1706 for Rectal Cancer Liver Metastases is a phase 2, interventional study registered as NCT06787183 by Fujian Cancer Hospital, with a registry enrolment figure of 42 participants, started 2025-12-01 and due to reach its primary completion in 2026-12-01. Interventions recorded: Short course radiotherapy; Capecitabine; Oxaliplatin; QL1706. Conditions listed: Locally Advanced Rectal Cancer With Liver Metastases. Primary outcome: Progression-free-Survival. Colorectal eligibility wording from the registry: "Pathologically confirmed rectal cancer with liver metastases (stage M1)". Sites: China. No results are recorded here; the registry entry is the source.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-09-24
- Tags: ctgov-ingest; colorectal-deep-dive
- Registry id: NCT06787183
- Phase: 2
- Setting: A Phase II Multicenter Clinical Trail of Efficacy and Safety of Short Course Radiotherapy Combined With CAPOX and PD-1/CTLA-4 Bispecific Antibody QL1706 in Patients With Liver Metastases From Rectal Cancer
- Sponsor: Fujian Cancer Hospital
- Enrolled: 42

## Sources

- ClinicalTrials.gov NCT06787183: https://clinicaltrials.gov/study/NCT06787183

## Connected records

- cancers: [Rectal cancer](https://onco.cc/cancers/rectal-cancer/)
- technologies: [Cytotoxic chemotherapy](https://onco.cc/technologies/cytotoxic-chemotherapy/), [IMRT / IGRT (modern external beam)](https://onco.cc/technologies/imrt-igrt/), [Platinum agents](https://onco.cc/technologies/platinum/)
- drugs: [Capecitabine](https://onco.cc/drugs/capecitabine/), [FOLFOX (5-FU, leucovorin, oxaliplatin)](https://onco.cc/drugs/folfox/), [QL1706](https://onco.cc/drugs/ql1706/)
- terms: [Colorectal cancer trials open today (registry snapshot)](https://onco.cc/terms/colorectal-trials-open-today/)

---
JSON: https://onco.cc/api/v1/entities/nct06787183.json